Australia markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
68.89+0.08 (+0.12%)
As of 11:13AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close68.81
Open69.36
Bid68.85 x 1000
Ask68.93 x 800
Day's range68.82 - 69.73
52-week range60.89 - 85.97
Volume2,439,870
Avg. volume9,953,084
Market cap86.414B
Beta (5Y monthly)0.66
PE ratio (TTM)N/A
EPS (TTM)-0.20
Earnings date22 Oct 2020 - 26 Oct 2020
Forward dividend & yield2.72 (3.94%)
Ex-dividend date14 Sep 2020
1y target est80.17
  • Diodes Incorporated Reports Second Quarter 2020 Financial Results
    Business Wire

    Diodes Incorporated Reports Second Quarter 2020 Financial Results

    Diodes Incorporated (Nasdaq: DIOD) today reported its financial results for the second quarter ended June 30, 2020.

  • Is Gilead Sciences a Buy After Its Disappointing Q2 Results?
    Motley Fool

    Is Gilead Sciences a Buy After Its Disappointing Q2 Results?

    Gilead Sciences (NASDAQ: GILD) beat Wall Street estimates when the big biotech announced its first-quarter results in late April. Last week, Gilead announced second-quarter results that were below analysts' expectations. Gilead has been in the news quite a bit in recent months thanks to the clinical success for its COVID-19 therapy remdesivir.

  • Better Buy: Gilead Sciences vs. Pfizer
    Motley Fool

    Better Buy: Gilead Sciences vs. Pfizer

    Gilead Sciences (NASDAQ: GILD) and Pfizer (NYSE: PFE) are two of the most competent pharmaceutical companies in the industry. Recently, Gilead has been in the headlines thanks to its much-discussed antiviral drug remdesivir, which appears to be somewhat beneficial for treating coronavirus infections in certain patient populations. It helps that Gilead was an attractive company well before the pandemic, with normalized trailing 12-month diluted earnings per share (EPS) of $3.90 in contrast with Pfizer's $1.98 and a robust profit margin of 21.8%, slightly trailing Pfizer's 28.8%.